Results 1 to 10 of about 1,633,428 (329)

Best practices for engaging with affected communities: chronic hepatitis B as a case study [PDF]

Infectious Diseases of Poverty
Hepatitis B is the single most common cause of liver cancer, affecting > 250 million people worldwide (mostly in resource limited communities) and killing > 1 million people annually. The condition is marked by poor rates of diagnosis (14%) and treatment
Thomas Tu, Nafisa Yussf, Lien Tran, Kim Ngo, Su Wang, Adi Mondel, Isabelle Purcell, Jacki Chen, Wendy Lo, Bright Ansah, Kenneth Kabagambe, Soumen Basu, Dee Lee, Supa Chantschool, Chris Munoz, Ivana Dragojevic, Marko Korenjak, Fiona Borondy-Jenkins, Yasmin Ibrahim, Beatrice Zovich, Chari Cohen   +20 more
doaj   +2 more sources

Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices

MMWR Recommendations and Reports, 2018
Summary Hepatitis B virus (HBV) is transmitted via blood or sexual contact. Persons with chronic HBV infection are at increased risk for cirrhosis and liver cancer and require medical care.
Noele P Nelson
exaly   +2 more sources

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Nature, 2009
Jacques Fellay, Alexander J Thompson, Mark S Sulkowski   +2 more
exaly   +2 more sources

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment

Journal of Patient-Reported Outcomes, 2021
Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland, Rhea Racho, Maureen Kamischke, Kate Moraras, Evangeline Wang, Chari Cohen, Stuart Kendrick   +6 more
doaj   +1 more source

Awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign

BMC Gastroenterology, 2022
Introduction In 2016 the World Health Organization (WHO) had adopted a global strategy to eliminate Hepatitis B (HBV) by 2030 through five core interventions.
Zhuo-zhi Lim, Jau shya Teo, Ah-Choon Tan, Teck Onn Lim   +3 more
doaj   +1 more source

Hepatic encephalopathy

Nature Reviews Disease Primers, 2022
Hepatic encephalopathy (HE) is a prognostically relevant neuropsychiatric syndrome that occurs in the course of acute or chronic liver disease. Besides ascites and variceal bleeding, it is the most serious complication of decompensated liver cirrhosis.
Dieter Häussinger, Radha K. Dhiman, Vicente Felipo, Boris Görg, Rajiv Jalan, Gerald Kircheis, Manuela Merli, Sara Montagnese, Manuel Romero-Gomez, Alfons Schnitzler, Simon D. Taylor-Robinson, Hendrik Vilstrup   +11 more
openaire   +10 more sources

Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination [PDF]

Journal of Preventive Medicine and Public Health, 2021
Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or ...
Nathalie Brunner, Philip Bruggmann
doaj   +1 more source

The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?

Archives of Public Health, 2021
Background Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC).
Tomoyuki Hayashi, Yumie Takeshita, Yvan J.-F. Hutin, Hande Harmanci, Philippa Easterbrook, Sarah Hess, Judith van Holten, Ena Oghenekaro Oru, Shuichi Kaneko, Cihan Yurdaydin, Marc Bulterys   +10 more
doaj   +1 more source

Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study

BMC Public Health, 2021
Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland, Sean Farrell, Priyanka Kumar, Maureen Kamischke, Michaela Jackson, Sierra Bodor, Timothy M. Block, Rosemary Frasso, Chari Cohen   +8 more
doaj   +1 more source

Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project

Harm Reduction Journal, 2022
Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts.
Julia A. Silano, Carla Treloar, Kyle Leadbeatter, Sandy Davidson, Justine Doidge   +4 more
doaj   +1 more source